Nuwellis (NUWE) Net Cash Flow Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.56% |
| Dec 31, 2025 | 10.91% |
| Sep 30, 2025 | -16.37% |
| Jun 30, 2025 | -2.50% |
| Mar 31, 2025 | -20.85% |
| Dec 31, 2024 | 27.41% |
| Sep 30, 2024 | 17.46% |
| Jun 30, 2024 | 37.97% |
| Mar 31, 2024 | -19.11% |
| Dec 31, 2023 | 16.34% |
| Sep 30, 2023 | -39.22% |
| Jun 30, 2023 | 5.66% |
| Mar 31, 2023 | -4.06% |
| Dec 31, 2022 | 10.09% |
| Sep 30, 2022 | -1.59% |
| Jun 30, 2022 | -24.70% |
| Mar 31, 2022 | -75.20% |
| Dec 31, 2021 | -107.64% |
| Sep 30, 2021 | 19.09% |
| Jun 30, 2021 | 2.38% |
| Mar 31, 2021 | 32.12% |
| Dec 31, 2020 | 6.03% |
| Sep 30, 2020 | 30.89% |
| Jun 30, 2020 | 21.05% |
| Mar 31, 2020 | -5.23% |
| Dec 31, 2019 | 15.20% |
| Sep 30, 2019 | 7.37% |
| Jun 30, 2019 | 5.09% |
| Mar 31, 2019 | 23.69% |
| Dec 31, 2018 | 14.05% |
| Sep 30, 2018 | -49.78% |
| Jun 30, 2018 | -18.45% |
| Mar 31, 2018 | -9.41% |
| Dec 31, 2017 | 43.36% |
| Sep 30, 2017 | -17.02% |
| Jun 30, 2017 | 31.24% |
| Mar 31, 2017 | 16.23% |
| Dec 31, 2016 | 16.42% |
| Sep 30, 2016 | -36.81% |
| Jun 30, 2016 | -5.60% |
| Mar 31, 2016 | -19.65% |